BNB treasury company plunges 77% after Nasdaq delisting notice
Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
Why this matters
This altcoin story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Evernorth Holdings shares rise 5% in Nasdaq debut as XRP treasury firm goes public
Evernorth's Nasdaq debut highlights growing institutional interest in crypto, offering traditional investors a regulated entry int...
Solana Treasury Firm DeFi Development Keeps Buying SOL as CHAD Preferred Stock Hits Record
The Nasdaq-listed company now holds about 2.59 million SOL, but its weekly purchases keep shrinking.
Russia Adds Sberbank to Crypto Exchange Register, Joining 9 Firms Before Dec. 1 Launch
Key Takeaways: The Central Bank of Russia has granted Sberbank permission to provide cryptocurrency exchange. Nine companies were...
Tom Lee’s Bitmine Nears 5% of Ether Supply, Trims Weekly Buy to 12,532 ETH
Bitmine Immersion Technologies (NYSE: BMNR) held 6,028,946 ETH as of Oct. 11, the Ethereum treasury company said in a press releas...
Citadel Securities and BNY separately advance tokenized US Treasury initiatives
Tokenized Treasuries could revolutionize financial markets by enabling 24/7 trading and settlement, potentially increasing liquidi...
Bitcoin defies $800 million crypto wipeout as South Korea’s AI stock market crashes
Bitcoin rebounded above $83,000 on Tuesday despite a sharp Asian stock selloff, as cryptocurrency liquidations exceeded $800 milli...